Axcelis Technologies, Inc. has announced a revised timeline for its merger with Veeco Instruments Inc., now expected to close by the end of the first quarter of 2027. This update, shared in a recent SEC filing, reflects the ongoing regulatory processes that are critical for the semiconductor equipment industry.
The merger, originally announced on September 30, 2025, involves Axcelis’s wholly-owned subsidiary merging with Veeco, allowing Veeco to operate as a subsidiary of Axcelis. The completion of this transaction is contingent upon meeting customary closing conditions, including regulatory approval from the State Administration for Market Regulation of the People’s Republic of China (SAMR).
In the filing dated November 2, 2026, Axcelis stated, "Axcelis now expects the Merger to close by the end of the first quarter of 2027 subject to the satisfaction or waiver of all closing conditions." However, the company also cautioned that there are no guarantees that the closing will occur on this timeline.
Furthermore, due to the pending expiration of the current clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the parties plan to make a new submission under the HSR Act promptly. The merger's closing is also dependent on the expiration or early termination of the HSR Act waiting period for this new submission.
Axcelis Technologies, a Delaware corporation, is classified under the SIC code 3559, which pertains to Special Industry Machinery, NEC. The company trades on the Nasdaq under the ticker symbol ACLS. In the context of the semiconductor equipment sector, this merger is significant as it may reshape competitive dynamics and influence market strategies.
Axcelis and Veeco have both been active in the semiconductor space, and this merger is expected to create synergies that could enhance their collective market position. The filing indicates that both companies are working constructively with regulatory bodies to ensure a smooth approval process.
As the merger progresses, industry stakeholders will be watching closely for updates, particularly regarding regulatory approvals and the strategic implications of the merger for both companies. The filing does not specify what happens next, but it emphasizes the importance of regulatory compliance in finalizing the merger.
Read Next
Lloyds Banking Group Director Acquires 41,375 Shares
New York Stock Exchange to Remove LiveRamp Holdings from Listing
Bonventre Joseph cancels over 211,000 shares in merger
Cherone Mark cancels 29,866 shares amid merger agreement
Andrawis Nabil cancels over 50,000 shares in merger deal
Brunner Nathan Disposes of Shares Amid Merger Agreement









